Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$202.57

1.46 (0.73%)

09:07
11/04/19
11/04
09:07
11/04/19
09:07

Nvidia price target raised to $200 from $165 at Craig-Hallum

Craig-Hallum analyst Richard Shannon raised his price target for Nvidia to $200 from $165 ahead of the company's Q3 results, which he expects to be "strong." In a research note to investors, Shannon says he believes Nvidia's Gaming unit is likely to report upside to consensus estimates based on stronger low-end/mid-range GPU sales and lower channel inventory. Though he views Nvidia's near-term prospects more favorably, Shannon says he is continuing to sit on the sidelines with his Hold rating as he feels valuations remain "stretched" and offer limited upside.

  • 14

    Nov

  • 20

    Nov

NVDA Nvidia
$202.57

1.46 (0.73%)

10/15/19
BOFA
10/15/19
NO CHANGE
Target $250
BOFA
Buy
Nvidia price target raised to $250 from $225 at BofA/Merrill
BofA Merrill Lynch analyst Vivek Arya raised his price target on Nvidia shares to $250 from $225 as he believes the company's data center growth will soon benefit from "the next-big AI landmark," namely natural language processing, or "conversational AI." The ability to accurately listen, understand, speak and contextualize human speech needs compute requirements 100 times that of today's dominant image/video classifier AI machines, said Arya, who sees Nvidia being "in prime position" to benefit from this shift given its portfolio of hardware and software and its developer ecosystem. Arya keeps a Buy rating on Nvidia, which he continues to identify as his top large-cap pick.
10/21/19
MSCO
10/21/19
NO CHANGE
Target $32
MSCO
Equal Weight
AMD likely to gain share in every segment next year, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said he believes AMD (AMD) has "put itself in a remarkable position" of being poised to likely gain share in every segment next year by competing successfully with both Intel (INTC) and Nvidia (NVDA) while spending a fraction of the R&D those two spend. However, he keeps an Equal Weight rating on AMD shares, stating that his 2020 EPS estimate of $1.07 gives the company "quite a bit of credit for share gains" and the $1.50 in 2020 EPS that some investors are convinced about "is possible, but certainly not a given." Moore, who sees AMD's biggest gains in the "enthusiast desktop," servers for the largest scale cloud service providers, and data center graphics, raised his price target on the stock to $32 from $30.
10/22/19
WELS
10/22/19
NO CHANGE
Target $220
WELS
Outperform
Nvidia price target raised to $220 from $200 at Wells Fargo
Wells Fargo analyst Aaron Rakers raised his price target for Nvidia to $220 from $220, citing its co-founder and CEO Jensen Huang positive keynote presentation at MWC Los Angeles, platform strategy that is continuing to resonate, and an expectation of a return to growth in the company's data center segment. The analyst reiterates an Outperform rating on the shares.
10/25/19
RBCM
10/25/19
NO CHANGE
Target $251
RBCM
Outperform
Nvidia price target raised to $251 from $217 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on Nvidia (NVDA) to $251 and kept his Outperform rating after the results from Intel (INTC) indicated that data center demand was higher than expected. The analyst contends that Nvidia is also likely to experience a higher growth rate relative to CPU server demand, adding that he is also comfortable with his projections for its gaming business.

TODAY'S FREE FLY STORIES

MPWR

Monolithic Power

$169.05

4.15 (2.52%)

05:47
12/12/19
12/12
05:47
12/12/19
05:47
Initiation
Monolithic Power initiated  »

Monolithic Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$18.21

0.6 (3.41%)

05:35
12/12/19
12/12
05:35
12/12/19
05:35
Initiation
Huya initiated  »

Huya initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMAB

Genmab

, AZN

AstraZeneca

$48.19

0.23 (0.48%)

05:32
12/12/19
12/12
05:32
12/12/19
05:32
Downgrade
Genmab, AstraZeneca, Roche rating change  »

Genmab downgraded to Hold…

GMAB

Genmab

AZN

AstraZeneca

$48.19

0.23 (0.48%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

  • 17

    Dec

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

, MCK

McKesson

$143.40

0.59 (0.41%)

05:31
12/12/19
12/12
05:31
12/12/19
05:31
Hot Stocks
Walgreens Boots Alliance, McKesson create German wholesale JV »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

MCK

McKesson

$143.40

0.59 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MTUAY

MTU Aero Engines

$0.00

(0.00%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Downgrade
MTU Aero Engines rating change  »

MTU Aero Engines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, HALO

Halozyme

$18.74

-0.46 (-2.40%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Hot Stocks
Genentech says Phase III FeDeriCa study met primary endpoint »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

HALO

Halozyme

$18.74

-0.46 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

OEZVY

Verbund

$0.00

(0.00%)

05:28
12/12/19
12/12
05:28
12/12/19
05:28
Upgrade
Verbund rating change  »

Verbund upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALV

Autoliv

$83.17

0.81 (0.98%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Autoliv rating change  »

Autoliv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AMGN

Amgen

$233.96

0.14 (0.06%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Hot Stocks
Amgen, UCB announce EC approval of EVENITY »

Amgen and UCB announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$28.03

0.14 (0.50%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
BMW rating change  »

BMW upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$49.60

0.43 (0.87%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
Charles Schwab rating change  »

Charles Schwab upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVKIF

Evonik

$0.00

(0.00%)

05:22
12/12/19
12/12
05:22
12/12/19
05:22
Upgrade
Evonik rating change  »

Evonik upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLVY

Solvay

$0.00

(0.00%)

05:22
12/12/19
12/12
05:22
12/12/19
05:22
Downgrade
Solvay rating change  »

Solvay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLVY

Solvay

$0.00

(0.00%)

05:21
12/12/19
12/12
05:21
12/12/19
05:21
Upgrade
Solvay rating change  »

Solvay upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$86.59

0.56 (0.65%)

05:19
12/12/19
12/12
05:19
12/12/19
05:19
Upgrade
Starbucks rating change  »

Starbucks upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWI

SolarWinds

$18.28

0.1 (0.55%)

05:19
12/12/19
12/12
05:19
12/12/19
05:19
Recommendations
SolarWinds analyst commentary  »

SolarWinds remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$40.73

-0.77 (-1.86%)

05:14
12/12/19
12/12
05:14
12/12/19
05:14
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXRH

Texas Roadhouse

$57.25

0.55 (0.97%)

05:13
12/12/19
12/12
05:13
12/12/19
05:13
Initiation
Texas Roadhouse initiated  »

Texas Roadhouse initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DRI

Darden

$117.44

-1.15 (-0.97%)

05:11
12/12/19
12/12
05:11
12/12/19
05:11
Initiation
Darden initiated  »

Darden initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

EAT

Brinker

$41.12

-0.225 (-0.54%)

05:09
12/12/19
12/12
05:09
12/12/19
05:09
Initiation
Brinker initiated  »

Brinker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLMN

Bloomin' Brands

$21.95

-0.065 (-0.30%)

05:08
12/12/19
12/12
05:08
12/12/19
05:08
Initiation
Bloomin' Brands initiated  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$9.62

0.62 (6.89%)

05:05
12/12/19
12/12
05:05
12/12/19
05:05
Downgrade
Bright Scholar rating change  »

Bright Scholar downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$88.09

0.165 (0.19%)

04:59
12/12/19
12/12
04:59
12/12/19
04:59
Recommendations
Wayfair analyst commentary  »

Wayfair price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MD

Mednax

$26.75

1.975 (7.97%)

04:56
12/12/19
12/12
04:56
12/12/19
04:56
Upgrade
Mednax rating change  »

Mednax upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.